PF-07976016
- Generic Name
- PF-07976016
Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity
Phase 1
Active, not recruiting
- Conditions
- OverweightObesity
- Interventions
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 21
- Registration Number
- NCT06910839
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 252
- Registration Number
- NCT06717425
- Locations
- 🇺🇸
Artemis Institute for Clinical Research, San Diego, California, United States
🇺🇸Westside Center for Clinical Research, Jacksonville, Florida, United States
🇺🇸New Horizon Research Center, Miami, Florida, United States
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
Phase 1
Active, not recruiting
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 110
- Registration Number
- NCT06106009
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath